As of 2026-09-19, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is (35.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.11 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -277.1%.
The range of the Relative Valuation is (35.46) - (37.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 28.9x | 27.3x |
| Forward P/E multiples | 27.4x - 29.5x | 27.7x |
| Fair Price | (35.46) - (37.43) | (35.61) |
| Upside | -276.3% - -286.1% | -277.1% |
| Date | P/E |
| 2026-09-17 | -15.96 |
| 2026-09-16 | -15.26 |
| 2026-09-15 | -16.00 |
| 2026-09-14 | -16.15 |
| 2026-09-11 | -15.79 |
| 2026-09-10 | -15.85 |
| 2026-09-09 | -17.00 |
| 2026-09-08 | -16.17 |
| 2026-09-04 | -17.37 |
| 2026-09-03 | -17.75 |
| 2026-09-02 | -17.92 |
| 2026-09-01 | -16.47 |
| 2026-08-31 | -16.24 |
| 2026-08-28 | -16.11 |
| 2026-08-27 | -16.67 |
| 2026-08-26 | -15.03 |
| 2026-08-25 | -14.61 |
| 2026-08-24 | -14.00 |
| 2026-08-21 | -14.51 |
| 2026-08-20 | -14.84 |
| 2026-08-19 | -15.24 |
| 2026-08-18 | -13.92 |
| 2026-08-17 | -14.04 |
| 2026-08-14 | -13.98 |
| 2026-08-13 | -14.22 |
| 2026-08-12 | -14.19 |
| 2026-08-11 | -14.07 |
| 2026-08-10 | -13.27 |
| 2026-08-07 | -12.96 |
| 2026-08-06 | -12.96 |
| 2026-08-05 | -12.30 |
| 2026-08-04 | -12.66 |
| 2026-08-03 | -12.26 |
| 2026-07-31 | -11.47 |
| 2026-07-30 | -12.02 |
| 2026-07-29 | -12.00 |
| 2026-07-28 | -11.92 |
| 2026-07-27 | -12.27 |
| 2026-07-24 | -12.11 |
| 2026-07-23 | -12.26 |
| 2026-07-22 | -12.22 |
| 2026-07-21 | -12.52 |
| 2026-07-20 | -13.00 |
| 2026-07-17 | -13.30 |
| 2026-07-16 | -13.31 |
| 2026-07-15 | -13.60 |
| 2026-07-14 | -13.87 |
| 2026-07-13 | -14.53 |
| 2026-07-10 | -14.63 |
| 2026-07-09 | -15.85 |